2,3-Dibromo-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine, 95.0%, 5g

6-Fluoro-N-(4-fluorobenzyl)quinazolin-4-amine, 95.0%, 100mg

(2'S,3S)-1-(2-Methylamino-2-phenyl-ethyl)-pyrrolidin-3-ol, 97.0%, 1g

(1R,4R)-1-N-(Pyrimidin-2-yl)cyclohexane-1,4-diamine dihydrochloride, 1g

tert-Butyl 4-(2-methoxy-2-oxoethyl)piperidine-1-carboxylate, 95.0%, 100g

2-Amino-4-fluoropyridine, 98.0%, 1g

tert-butyl [trans-4-amino-1,1-dioxidotetrahydro-3-thienyl]carbamate, 95.0%, 250mg

Boc-4-Amino-D-Phe-OH, >99%, 25g

N-METHOXY-N-METHYLISOXAZOLE-3-CARBOXAMIDE, 95.0%, 100mg

(3,5-Difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol, 98%, 1g

Octanoic acid, min 99%, for synthesis, 1L, glass packaging

4-Pentenoic Acid>98.0%(GC)(T)100mL

Methyl 5-Fluoro-4-methoxy-3-(trifluoromethyl)benzoate, 98%, 250mg